A groundbreaking clinical study sponsored by Hospital Civil de Guadalajara is set to evaluate the effect of a pulmonary rehabilitation program on the diaphragmatic index in patients suffering from interstitial lung diseases. The study aims to measure improvement in respiratory function and quality of life markers.
This research is significant for clinical teams, quality assurance professionals, and regulatory stakeholders looking to understand interventions impacting chronic lung conditions.
What changed?
As of October 2025, the study listed on ClinicalTrials.gov is not yet recruiting participants. The research, titled “Evaluation of the Diaphragmatic Index Before and After a Pulmonary Rehabilitation Program,” represents a crucial step in advancing understanding of interstitial lung diseases. It combines evidence-based rehabilitation approaches with innovative biometrics to assess diaphragmatic function.
What does the study focus on?
The study targets patients diagnosed with diffuse interstitial lung diseases—a group of chronic conditions characterized by progressive scarring of lung tissue. Rehabilitation methods applied will include therapies designed to enhance respiratory efficiency and diaphragmatic performance.
Specifically, researchers aim to quantify changes in the diaphragmatic index pre- and post-intervention using objective measures. This index represents diaphragm movement and efficiency, critical factors influencing lung capacity and ventilation levels.
How could this improve quality of life?
Patients with interstitial lung diseases often experience reduced breathing ability and diminished life quality. By focusing on diaphragmatic efficiency, this study promises insights into targeted rehabilitation protocols to alleviate these burdens. Improved diaphragmatic function increases oxygen uptake efficiency, which can restore daily living activities and reduce fatigue.
This research could drive advancements in non-pharmacological interventions, aligning treatment pathways with global regulatory frameworks for safer, effective healthcare delivery.
Frequently Asked Questions
-
1. Who sponsors the study?
The study is sponsored by Hospital Civil de Guadalajara, a recognized institution in clinical research.
-
2. Are participants being recruited?
No. The study is not yet recruiting as per the information available on ClinicalTrials.gov.
-
3. What conditions does this study address?
The focus is on diffuse interstitial lung diseases, a category of chronic respiratory disorders.
-
4. How can this impact regulatory practices?
Data from this research could establish benchmarks for diaphragmatic index assessment, aligning with clinical safety and performance standards.
Conclusion
This upcoming study connects advanced rehabilitation techniques with measurable improvements in respiratory care for interstitial lung diseases. Its outcomes could shape future clinical guidelines for managing chronic respiratory conditions.
Disclaimer
This article is for informational purposes only and should not be considered legal or clinical advice. Professionals should consult specific regulations when applying study findings.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07205627?term=medical+device